Copyright
©The Author(s) 2017.
World J Stem Cells. Aug 26, 2017; 9(8): 133-143
Published online Aug 26, 2017. doi: 10.4252/wjsc.v9.i8.133
Published online Aug 26, 2017. doi: 10.4252/wjsc.v9.i8.133
Table 1 Characteristics of intracerebral haemorrhage patients and infuses for autologous bone marrow-derived mesenchymal stem cell therapy
| Patients | Sex/agein years | Location of haemorrhage | CT readout (cm) | Hemorrhage volume (mL) | MSC passage numbers | Viability (%) | MSC(× 107) | MSC/kg (× 105) |
| UPN02 | F/50 | Basal ganglia, left | 4.4 × 5.8 × 5.9 | 75 | 4, 7 | 96.8 | 3.1 | 5.44 |
| 3-5 | 92.1 | 3.2 | 5.61 | |||||
| 3-6 | 92.6 | 3.1 | 5.44 | |||||
| UPN08 | F/48 | Basal ganglia, left | 4.0 × 2.0 × 3.0 | 12 | 3, 4 | 95.8 | 1.43 | 2.65 |
| 3, 4 | 96.5 | 1.43 | 2.65 | |||||
| UPN09 | M/56 | Basal ganglia, right | 6.5 × 5.0 × 4.0 | 65 | 3-8 | 98.5 | 7.6 | 13.1 |
| 2-6 | 96.8 | 4 | 6.84 | |||||
| UPN10 | F/55 | Frontal lobe, right | 5.6 × 4.5 × 5.0 | 63 | 1-6 | 88.5 | 5.5 | 13.1 |
| 1-6 | 98 | 5.6 | 12.4 | |||||
| UPN11 | M/55 | Basal ganglia, left | 2.4 × 5.0 × 3.5 | 21 | 1-6 | 90.5 | 5.4 | 9 |
| 1-7 | 99 | 8.4 | 14.5 | |||||
| UPN05 | F/59 | Basal ganglia, left | 6.0 × 4.0 × 4.0 | 48 | ||||
| UPN06 | M/56 | Basal ganglia, frontoparietal temporal lobe, right | 7.3 × 3.5 × 5.0 | 64 | ||||
| UPN07 | M/41 | Basal ganglia, right | 4.3 × 6.4 × 5.0 | 69 | ||||
| UPN12 | M/50 | Basal ganglia, | NA | 55 | ||||
| putaminal, right |
- Citation: Tsang KS, Ng CPS, Zhu XL, Wong GKC, Lu G, Ahuja AT, Wong KSL, Ng HK, Poon WS. Phase I/II randomized controlled trial of autologous bone marrow-derived mesenchymal stem cell therapy for chronic stroke. World J Stem Cells 2017; 9(8): 133-143
- URL: https://www.wjgnet.com/1948-0210/full/v9/i8/133.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v9.i8.133